Both symptomatic and asymptomatic neurocognitive impairment in HIV are associated with a higher risk for low/very low viremia and viral failure. “The HIV landscape has changed quickly during the last 10 years,” Mattia Trunfio, MD, PhD, notes....
Infectious Disease
RELEVANT ARTICLES IN Infectious Disease
Twice-yearly azithromycin distribution reduces childhood mortality in rural Niger
Twice-yearly azithromycin distribution reduces childhood mortality in rural Niger
1. In this randomized cluster trial, twice-yearly azithromycin distribution reduced all-cause childhood mortality among children aged one to 59 months in rural communities in Niger. 2. Distribution of azithromycin was not effective at reducing infant mortality when...
Investigating the Impact of COVID-19 on Long-Term Symptoms and Psychosomatic Comorbidity
Investigating the Impact of COVID-19 on Long-Term Symptoms and Psychosomatic Comorbidity
The following is a summary of “Frequency, persistence and relation of disease symptoms, psychosomatic comorbidity and daily life impairment after COVID-19: a cohort study in general practice,” published in the August 2024 issue of Primary Care by Hapfelmeier et al....
Advertisement
Prognostic Risk Factors for Pyogenic Liver Abscess Caused by Klebsiella pneumoniae
Prognostic Risk Factors for Pyogenic Liver Abscess Caused by Klebsiella pneumoniae
The following is a summary of “Prognostic risk factors for pyogenic liver abscess caused by Klebsiella pneumoniae,” published in the September 2024 issue of Gastroenterology by Lyu et al. Pyogenic liver abscesses (PLA) caused by Klebsiella pneumoniae can vary in...
Age Not Recommended as Eligibility Criterion for ECMO in Patients With ARDS
Age Not Recommended as Eligibility Criterion for ECMO in Patients With ARDS
The following is a summary of “Role of age as eligibility criterion for ECMO in patients with ARDS: meta-regression analysis,” published in the August 2024 issue of Critical Care by Tonetti et al. The use of age as an eligibility criterion for V-V ECMO has been...
Transcriptomic Changes in Subjects With T. Cruzi Infection- Pre- And Post-treatment
Transcriptomic Changes in Subjects With T. Cruzi Infection- Pre- And Post-treatment
The following is a summary of “Transcriptomic evidence of immune modulation in subjects with chronic Trypanosoma cruzi infection,” published in the August 2024 issue of Infectious Disease by Ros-Lucas et al. Millions of people are affected by Chagas disease, a...
Twice-yearly azithromycin distribution reduces childhood mortality in rural Niger
Twice-yearly azithromycin distribution reduces childhood mortality in rural Niger
1. In this randomized cluster trial, twice-yearly azithromycin distribution reduced all-cause childhood mortality among children aged one to 59 months in rural communities in Niger. 2. Distribution of azithromycin was not effective at reducing infant mortality when...
Investigating the Impact of COVID-19 on Long-Term Symptoms and Psychosomatic Comorbidity
Investigating the Impact of COVID-19 on Long-Term Symptoms and Psychosomatic Comorbidity
The following is a summary of “Frequency, persistence and relation of disease symptoms, psychosomatic comorbidity and daily life impairment after COVID-19: a cohort study in general practice,” published in the August 2024 issue of Primary Care by Hapfelmeier et al....
Prognostic Risk Factors for Pyogenic Liver Abscess Caused by Klebsiella pneumoniae
Prognostic Risk Factors for Pyogenic Liver Abscess Caused by Klebsiella pneumoniae
The following is a summary of “Prognostic risk factors for pyogenic liver abscess caused by Klebsiella pneumoniae,” published in the September 2024 issue of Gastroenterology by Lyu et al. Pyogenic liver abscesses (PLA) caused by Klebsiella pneumoniae can vary in...
Age Not Recommended as Eligibility Criterion for ECMO in Patients With ARDS
Age Not Recommended as Eligibility Criterion for ECMO in Patients With ARDS
The following is a summary of “Role of age as eligibility criterion for ECMO in patients with ARDS: meta-regression analysis,” published in the August 2024 issue of Critical Care by Tonetti et al. The use of age as an eligibility criterion for V-V ECMO has been...
Transcriptomic Changes in Subjects With T. Cruzi Infection- Pre- And Post-treatment
Transcriptomic Changes in Subjects With T. Cruzi Infection- Pre- And Post-treatment
The following is a summary of “Transcriptomic evidence of immune modulation in subjects with chronic Trypanosoma cruzi infection,” published in the August 2024 issue of Infectious Disease by Ros-Lucas et al. Millions of people are affected by Chagas disease, a...
Advertisement
CROI 2023
The latest news from CROI 2023 on HIV, includes abstracts, featured articles, and information about the conference.
Advertisement
Medications in Obesity Treatment: Types, Benefits, and Considerations
Medications in Obesity Treatment: Types, Benefits, and Considerations
Dr. Jill Bryson explains which medications can be beneficial when incorporated into an obesity treatment plan, and factors that determine medication use.
Drawing the Line When “Curbsiding”
Drawing the Line When “Curbsiding”
Dr. MedLaw discusses where the line between safely offering informal consultation, or "curbsiding," and taking on the liability of a consultation gets drawn.
Should Families Be Allowed to Attend Code Events?
Should Families Be Allowed to Attend Code Events?
Clear guidelines and flexibility regarding family presence at code events in the ICU are essential as patients, families, and care settings vary widely.
CME / CE
PODCAST
Biomarker Testing and NSCLC, Part 1
Sep 04, 2024
The Influence of Nutrition on Sleep Patterns
Aug 21, 2024Advertisement
MORE STORIES IN Infectious Disease
FILTER ARTICLES BY:
Advertisement
PODCAST
Biomarker Testing and NSCLC, Part 1
Sep 04, 2024The Influence of Nutrition on Sleep Patterns
Aug 21, 2024CARTOONS
Elbowing In
Elbowing In
Medical cartoon in which man needs an elbow specialist, but meets Joint Chief of Staff.
Big Pill to Swallow
Big Pill to Swallow
Medical cartoon in which the pharmacist is giving the customer a prescription bottle containing one huge, once-a-year pill.
You Gonna Finish That?
You Gonna Finish That?
Medical cartoon by Jonny Hawkins about patient asking another patient about finishing IV bag.
BUSINESS OF MEDICINE
Drawing the Line When “Curbsiding”
Drawing the Line When “Curbsiding”
Dr. MedLaw discusses where the line between safely offering informal consultation, or "curbsiding," and taking on the liability of a consultation gets drawn.
How Cash-Based Healthcare May Benefit Both Patients and Physicians
How Cash-Based Healthcare May Benefit Both Patients and Physicians
Cash-based healthcare aims to provide all individuals with vital healthcare services, eliminating the burden of navigating insurance company requirements.
What the Re-Classification of Cannabis as a Schedule III Drug Means for Physicians
What the Re-Classification of Cannabis as a Schedule III Drug Means for Physicians
Physicians should educate themselves on the benefits of medical marijuana, recognizing that cannabis may soon be re-classified as a Schedule III drug.
ADVERTISEMENT
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.